Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Jones

Showing results (571-580 of 600) with videos related to

Pageof 60
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Aerosolized Syk antisense suppresses Syk expression, mediator release from macrophages, and pulmonary inflammationG R Stenton, M K Kim, O Nohara, et al.
Acta Oncologica (Stockholm, Sweden)|March 14, 2018
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patientsE Palmerini, R L Jones, E Setola, et al.
ESMO Open|January 9, 2024
Novel trial designs for patients with gastrointestinal stromal tumorC Serrano, S Rothschild, G Villacampa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 26, 2025
Double burden: financial toxicity in patients with advanced soft tissue sarcoma at the start of first-line palliative chemotherapy: baseline data from the HOLISTIC studyE Roets, E Younger, R L Jones, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2015
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reportingE Wardelmann, R L Haas, J V M G Bovée, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 28, 2019
Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma CentreC Drabbe, C Benson, E Younger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 8, 2018
Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcomaR L Jones, G D Demetri, S M Schuetze, et al.
Acta Oncologica (Stockholm, Sweden)|November 15, 2016
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysisA Kollár, R L Jones, S Stacchiotti, et al.
Science (New York, N.Y.)|October 18, 2008
The extreme Kuiper Belt binary 2001 QW322J-M Petit, J J Kavelaars, B J Gladman, et al.
ESMO Open|June 19, 2022
Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma NetworkA Smrke, A M Frezza, C Giani, et al.
Pageof 60

Showing results (571-580 of 600) with videos related to

Sort By:
Pageof 60
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2000
Aerosolized Syk antisense suppresses Syk expression, mediator release from macrophages, and pulmonary inflammationG R Stenton, M K Kim, O Nohara, et al.
Acta Oncologica (Stockholm, Sweden)|March 14, 2018
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patientsE Palmerini, R L Jones, E Setola, et al.
ESMO Open|January 9, 2024
Novel trial designs for patients with gastrointestinal stromal tumorC Serrano, S Rothschild, G Villacampa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 26, 2025
Double burden: financial toxicity in patients with advanced soft tissue sarcoma at the start of first-line palliative chemotherapy: baseline data from the HOLISTIC studyE Roets, E Younger, R L Jones, et al.
European Journal of Cancer (Oxford, England : 1990)|December 25, 2015
Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reportingE Wardelmann, R L Haas, J V M G Bovée, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 28, 2019
Embryonal and Alveolar Rhabdomyosarcoma in Adults: Real-Life Data From a Tertiary Sarcoma CentreC Drabbe, C Benson, E Younger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 8, 2018
Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcomaR L Jones, G D Demetri, S M Schuetze, et al.
Acta Oncologica (Stockholm, Sweden)|November 15, 2016
Pazopanib in advanced vascular sarcomas: an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) retrospective analysisA Kollár, R L Jones, S Stacchiotti, et al.
Science (New York, N.Y.)|October 18, 2008
The extreme Kuiper Belt binary 2001 QW322J-M Petit, J J Kavelaars, B J Gladman, et al.
ESMO Open|June 19, 2022
Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma NetworkA Smrke, A M Frezza, C Giani, et al.
Pageof 60